Edward G. Broenniman - Sep 15, 2022 Form 4 Insider Report for AETHLON MEDICAL INC (AEMD)

Role: Director
Signature: /s/ Edward G. Broenniman, by: James B. Frakes, Attorney-in-fact
Stock symbol: AEMD
Transactions as of: Sep 15, 2022
Transactions value $: $0
Form type: 4
Date filed: 9/16/2022, 11:10 AM
Previous filing: Mar 31, 2022
Next filing: Oct 4, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AEMD	Common Stock	Award	$0	+34.2K	+96.78%	$0.00	69.6K	Sep 15, 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The RSU was granted on 4/1/22, but was contingent on stockholder approval of an increase in the shares issuable under the Issuer's 2020 Equity Incentive Plan at the Issuer's annual meeting of stockholders held on 9/15/22, and therefore for purposes of Section 16 the RSU was not "acquired" until such stockholder approval was obtained. 50% of the shares subject to the RSU will vest on 9/30/22, and 25% of the RSU's will vest on each of 12/31/22 and 3/31/23, subject to continuous service through each such date.

Content

The RSU was granted on 4/1/22, but was contingent on stockholder approval of an increase in the shares issuable under the Issuer's 2020 Equity Incentive Plan at the Issuer's annual meeting of stockholders held on 9/15/22, and therefore for purposes of Section 16 the RSU was not "acquired" until such stockholder approval was obtained. 50% of the shares subject to the RSU will vest on 9/30/22, and 25% of the RSU's will vest on each of 12/31/22 and 3/31/23, subject to continuous service through each such date.